Callan Family Office, LLC Teva Pharmaceutical Industries LTD Transaction History
Callan Family Office, LLC
- $1.57 Trillion
- Q4 2024
A detailed history of Callan Family Office, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Callan Family Office, LLC holds 9,389 shares of TEVA stock, worth $153,416. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,389Holding current value
$153,416% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
650Shares Held
583MCall Options Held
17.4MPut Options Held
7.13M-
Black Rock Inc. New York, NY43MShares$702 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$637 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$592 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$471 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$444 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.1B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...